Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Growth (Status and Outlook) 2023-2029

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Growth (Status and Outlook) 2023-2029

Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.

LPI (LP Information)' newest research report, the “Digital PCR (dPCR) and Real-Time PCR (qPCR) Industry Forecast” looks at past sales and reviews total world Digital PCR (dPCR) and Real-Time PCR (qPCR) sales in 2022, providing a comprehensive analysis by region and market sector of projected Digital PCR (dPCR) and Real-Time PCR (qPCR) sales for 2023 through 2029. With Digital PCR (dPCR) and Real-Time PCR (qPCR) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital PCR (dPCR) and Real-Time PCR (qPCR) industry.

This Insight Report provides a comprehensive analysis of the global Digital PCR (dPCR) and Real-Time PCR (qPCR) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Digital PCR (dPCR) and Real-Time PCR (qPCR) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital PCR (dPCR) and Real-Time PCR (qPCR) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital PCR (dPCR) and Real-Time PCR (qPCR) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital PCR (dPCR) and Real-Time PCR (qPCR).

The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market size is projected to grow from US$ 1286.4 million in 2022 to US$ 1528 million in 2029; it is expected to grow at a CAGR of 2.5% from 2023 to 2029.

Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.

North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.

In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital PCR (dPCR) and Real-Time PCR (qPCR) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
dPCR
qPCR

Segmentation by application
Clinical
Research Institution
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Roche
QIAGEN
Bio-rad
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
Fluidigm
RainDance Technologies

Please note: The report will take approximately 2 business days to prepare and deliver.